Net Loss per Share (Tables)

6 Months Ended

Jun. 30, 2024

Earnings Per Share [Abstract]

Schedule of Weighted-Average Common Shares Outstanding

The following securities are the weighted-average common shares outstanding used to calculate basic and diluted net loss per common share:

	Three Months Ended June 30,				Six Months Ended June 30,
	2024		2023		2024		2023
Common stock		35,641,878		9,142,633		34,037,201		8,657,206
March 2022 pre-funded warrants		-		1,280,965		-		1,280,965
May 2023 Tranche A pre-funded warrants		2,241,352		-		2,325,091		-
May 2023 Tranche B pre-funded warrants		451,632		-		451,632		-
October 2023 pre-funded warrants		296,703		-		606,044		-
Total		38,631,565		10,423,598		37,419,968		9,938,171

Schedule of Potentially Dilutive Securities Outstanding Excluded from Computations of Diluted Weighted-Average Shares Outstanding

The following potentially dilutive securities outstanding have been excluded from the computations of diluted weighted-average shares outstanding for the periods presented because such securities have an antidilutive impact due to losses reported (in common stock equivalent shares):

	As of June 30,
	2024		2023
Warrants issued to 2010/2012 convertible note    holders to purchase common stock		6,804		6,804
Warrants issued to underwriter to purchase common stock		1,100		1,100
2018 PIPE warrants		-		34,241
March 2022 common warrants		1,483,743		4,000,000
May 2023 Tranche A warrants		-		8,598,870
May 2023 Tranche B warrants		5,775,000		14,000,000
Options to purchase common stock		3,305,259		2,230,016
Outstanding restricted stock units		256,030		424,244
Total		10,827,936		29,295,275